Activation of Hageman factor (Factor XII) upon exposure to negatively charged agents has been attributed to proteolytic cleavage of this molecule. To examine this question, purified Hageman factor was exposed to Sephadex gels to which ellagic acid had been adsorbed. Such Hageman factor, separated from the gels and studied in the fluid phase, was amidolytic. Nonetheless, no cleavage of Hageman factor treated in this way could be demonstrated by sodium dodecyl sulfate/ polyacrylamide gel electrophoresis. Thus, activation of Hageman factor by negatively charged agents was not necessarily accompanied by molecular scission.
MATERIALS AND METHODS
Normal human plasma was separated from venous blood containing 1/50th vol of 0.5 M sodium citrate buffer (pH 5.0). A standard pool of normal adult plasmas was said to contain HF, plasma prekallikrein, HMWK, and PTA, each at 1 unit/ml (7) . Crude immunoglobulins were separated from normal rabbit serum or from monospecific rabbit antiserums to human HF (8) , kallikrein (9) , HMWK (10) , and plasminogen (Behring Diagnostics, Somerville, NJ) (6, 11) . Ellagic acid was dissolved as described (6) .
Sephadex-ellagic acid was prepared by mixing Sephadex G-10 (Pharmacia) that had been swollen in barbital/saline buffer (pH 7.5) with 0.1 mM ellagic acid, as described (6) .
[Unless otherwise noted, the term buffer refers to barbital/saline buffer (25 mM sodium barbital/125 mM sodium chloride at pH 7.5)]. The Sephadex-ellagic acid was washed repeatedly in buffer, reducing the content of ellagic acid in the washes to less than 0.1 ,uM. Sephadex/buffer was prepared in the same way, omitting ellagic acid (6) .
Purified HF (12) varied in specific activity from 63 to 83 units/mg of protein. 125I-labeled HF [125I-HF, 30,Ci/,ug (1 Ci = 3.7 X 1010 becquerels)] was dissolved in buffer or in 0.1% bovine albumin in buffer (8) . Partially purified bovine thrombin, depleted of Stuart factor (Factor X), contained 41 National Institutes of Health units/ml (1250 units/mg of protein) in 50 mM sodium phosphate buffer (pH 7.0) and was diluted in buffer before use (13) .
Bovine serum albumin (crystallized; Miles) was dissolved at a concentration of 1% in buffer.
H-D-phenylalanyl-L-pipecolyl-L-arginine'-p-nitroanilide (S2238, Ortho Diagnostics, Raritan, NJ) was dissolved in water at 1 mM and stored at 4°C. Imidazole/Tris/saline buffer (pH 8.2) contained 25 mM Tris-HCI (Sigma) and sufficient sodium chloride to provide an ionic strength of 0.15.
Purified HF was "activated" by exposure to Sephadex-ellagic acid in the presence of bovine serum albumin as described (6) .
Amidolytic activity was measured in the supernatant of mixtures of purified HF, albumin, and Sephadex-ellagic acid, as noted in the footnote to Table 1 .
The molecular size of 1251-HF that had been exposed to Sephadex-ellagic acid was measured by sodium dodecyl sulfate (NaDodSO4)/polyacrylamide gel electrophoresis after reduction by 2-mercaptoethanol. A sample of 0.3 ml of 125I-HF (approximately 2 X 105 cpm) was mixed with 1.0 ml of settled Sephadex-ellagic acid or Sephadex/buffer and centrifuged at 1800 X g for 15 min at 2°C. Supernatant (0.15 ml) was incubated with 0.15 ml of 4% NaDodSO4 in 2% 2-mercaptoethanol/10 mM sodium phosphate buffer (pH 7.0) or NaDodSO4 alone overnight at room temperature. Samples (0.2 ml) were then subjected to gel electrophoresis (14) . In other experiments, 0.2 ml of a mixture of 125I-HF (approximately 8 X 104 cpm) and unlabeled HF [final concentration 2.5 units (4.6 jug/ml)] was mixed with 2.0 ml of settled volume of Sephadex-ellagic acid or Sephadex/buffer, and the mixture was centrifuged at 30,000 X g for 15 min at 2°C. Supernatant (0.1 ml) was incubated with 0.1 ml of 4% NaDodSO4/2% 2-mercaptoethanol/10 mM sodium phosphate buffer (pH 7.0) for 3 min at 1000C. Samples were then subjected to 6% polyacrylamide gel electrophoresis. The gels were fixed and stained with Coomassie blue and quick-frozen on blocks of solid carbon dioxide. Slices 2 mm in width were cut with a gel slicer (Mickel Laboratory Engineering, Co., Surrey, England), and radioactivity was measured in a Nuclear Chicago gamma counter (model 1085). Molecular weight was estimated in comparison to bovine serum albumin (Mr 67,000), human transferrin (Behringwerke, A. G., West Germany, Mr 88,000), and pepsin (Worthington, Mr 35,000).
Abbreviations: HF, Hageman factor; PTA, plasma thromboplastin antecedent; HMWK, high molecular weight kininogen; S2238, H-D-phenylalanyl-L-pipecolyl-L-arginine-p-nitroanilide; NaDodSO4, sodium dodecyl sulfate. 1461
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To determine whether enzymatic properties emerged when HF was exposed to Sephadex-ellagic acid, purified HF was mixed with this gel, and, after centrifugation, the super atant solution was incubated with S2238. Weak amidolytic activity evolved; under the conditions tested, amidolysis by bovine thrombin was 600-fold greater on a molar basis (Table 1) (4) reported that HF was severed within an internal disulfide loop when plasma was exposed to glass and suggested that activation of HF depended upon this proteolytic change. These experiments were readily confirmed (Fig. 1A) . In contrast, significant cleavage of HF was not observed under the conditions used in the present study. When 125I-HF in bovine-serum albumin was exposed to Sephadexellagic acid, a peak of radioactivity corresponding to a Mr Of approximately 80,000 was found upon NaDodSO4/gel electrophoresis (Fig. 1B) ; the yield was usually about 1/10th of that obtained when 125I-HF was exposed to Sephadex/buffer (Fig.  IC) , in agreement with experiments of the coagulant activity of HF exposed to Sephadex-ellagic acid (6) . When HF treated in this way was reduced before electrophoresis, little or no evidence of cleavage within a disulfide loop was obtained. In four of six experiments, a small increment of radioactivity, approximately 1 .5% of that of the 80,000 Mr peak, was seen in one slice of the gel at a site corresponding to a Mr of 53,000 (Fig.  1B) ; none was seen in the other two trials. No increment in radioactivity was observed in slices corresponding to a Mr of about 30,000. In these experiments, the proportion of HF to Sephadex-ellagic acid was less than in the functional experiments described earlier (6) . When sufficient unlabeled HF was mixed with 125I-HF to duplicate these functional studies, no significant cleavage of HF was observed. 125I-HF was also added to nornal plasma and exposed to Sephadex-ellagic acid, and the supernatant was reduced before NaDodSO4/gel electrophoresis. Under these conditions, as much as 15% of the HF appeared to be converted to a 53,000 Mr species. DISCUSSION How negatively charged substances convert HF to an enzymic form is uncertain. Two views, not mutually exclusive, have been proposed: (i) HF undergoes a conformational change upon exposure to negatively charged substances that bring enzymatically active groups to its surface (1-3), and (ii) activation of HF requires its proteolytic cleavage (4, 5) . The present study approaches this question by utilizing a novel technique for preparation of fluid-phase HF that has been altered by a negatively charged agent, ellagic acid. HF, treated in this way, activates PTA, but only if HMWK is present in the substrate, HF-deficient plasma (6) . Such experiments suggest that HMWK may be needed for expression of the coagulant properties of activated HF rather than for activation of HF. Support for this view came from studies of purified HF. This agent, when exposed to Sephadex-ellagic acid, hydrolyzed S2238 as well as correcting the clotting defect of HF-deficient plasma. HMWK was not needed for conversion of HF to its amidolytic form. These studies do not rule out an undetected change in HF during purification, nor that the amidolytic properties of HF belonged to molecules that were not clot-promoting.
Human HF is a single-chain molecule of about Mr 80,000 (1, 15) . When partially digested by plasmin (5, 16), trypsin (17, 18) , or plasma kallikrein (19) , a subunit of Mr about 30,000 is separated that readily converts plasma prekallikrein to kallikrein but is much less effective in activating PTA. Revak et al. (4) reported that purified 125I-HF, mixed with human plasma, was cleaved upon exposure to glass, first within an internal disulfide loop, changing HF to a two-chain species, and then more slowly into its high and low molecular weight subcomponents. Revak its proteolytic scission, 125I-HF was exposed to Sephadex-ellagic acid"and studied by NaDodSO4/gel electrophoresis. Cleavage of purified 125I-HF upon exposure to Sephadex-ellagic acid was minimal, although this procedure activated coagulant and amidolytic properties. When HF treated in this way was reduced and subjected to NaDodSO4/gel electrophoresis, neither separation of the Mr 30,000 fragment nor significant scission of HF within an internal disulfide loop was observed. In fact, the same result was obtained earlier in mixtures of purified HF and ellagic acid (10) . Some cleavage-as much as 15%-was observed when 125I-HF was mixed with normal human plasma containing plasma prekallikrein and other plasma proenzymes. In this experiment, plasma was diluted 50% with the 125I-HF solution before exposure to Sephadex-ellagic acid. Revak et al. (4) , in contrast, diluted plasma 1:6 before exposure to glass, and, in more recent studies, scission of HF was enhanced by still greater dilution (20 Analysis by NaDodSO4/polyacrylamide gel electrophoresis of 125I-HF that had been exposed to glass in the presence of normal plasma. 125I-HF in 0.1% bovine serum albumin was mixed in a 10 X 75 mm polystyrene tube with an equal volume of normal plasma that had been diluted 1:25 in buffer. Samples of 0.02 ml (approximately 7 X 104 cpm) were transferred to 10 X 75 mm glass tubes. At 0 min or after shaking these tubes for 20 min at room temperature, 0.05 ml of 4% NaDodSO4 in 2% 2-mercaptoethanol was added to the tubes, which were then boiled for 3 min. Samples were subjected to NaDodSO4/6% polyacrylamide gel electrophoresis. The gel was sliced and assayed for radioactivity. The vertical axes indicate cpm (left) and % radioactivity relative to the total added to the gel (right), and the horizontal axis, successive slices of gel with the anode at the right. Dotted line, electrophoretic pattern at 0 min; solid line, electrophoretic pattern after 20 min of exposure to the glass tube. (B) Analysis by NaDodSO4/gel electrophoresis of 125I-HF exposed to Sephadexellagic acid. Three-tenths milliliter of 125I-HF in 0.1% bovine serum albumin was mixed with 1.0 ml of Sephadex-ellagic acid and centrifuged at 30,000 X g for 15 min at 2'C. Supernatant (0.15 ml) was incubated with 0.15 ml of 4% NaDodSO4 with or without 2% 2-mercaptoethanol in 10 mM sodium phosphate buffer (pH 7.0) overnight at room temperature. Two-tenths milliliter was then subjected to NaDodSO4/6% polyacrylamide gel electrophoresis. (C) Analysis by NaDodSO4/gel electrophoresis of 125I-HF exposed to Sephadex/ buffer. The same procedure was used as in B except that Sephadexellagic acid was replaced by Sephadex/buffer.
